Fresenius Medical Care AG(FMS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,602 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
FMS Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Fresenius Medical Care AG (FMS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores FMS at 50.4/100 on a 32-signal composite quality model, placing it at rank #1,602 of 2,962 stocks — the bottom half of the AI-ranked universe. FMS scores in the top quartile across revenue scale (91.5). Areas of concern include revenue growth (18.9) and institutional flow (22.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q4 2016), Fresenius Medical Care AG reports net income of $388.1M, free cash flow of $561.2M. Top institutional holders of FMS by reported 13-F value include PZENA INVESTMENT MANAGEMENT, MORGAN STANLEY, DODGE & COX, based on the most recent SEC filings. FMS trades on the NYSE exchange and files with the SEC under CIK 1333141. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FMS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Fresenius Medical Care AG directly from SEC EDGAR. Fresenius Medical Care AG's 13F Pro composite quality score has ranged between 50 and 57 since 2026, currently 50.4 — a declining long-term trajectory across 47 quarterly and live scoring snapshots.
Net Income
Q4 2016
$388.1M
Free Cash Flow
Q4 2016
$561.2M
ROIC
Q4 2016
15.2%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+1.5% YoYTotal Assets
-7.6% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $19.63B +1.5% | $19.34B -0.6% | $19.45B +0.3% | $19.40B +10.1% | $17.62B -1.3% | $17.86B |
| Total Assets | $31.00B -7.6% | $33.57B -1.1% | $33.93B -5.1% | $35.75B +4.0% | $34.37B +8.4% | $31.69B |
Get alerted when FMS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Fresenius Medical Care AG including:
Top Institutional Holders of FMS
PZENA INVESTMENT MANAGEMENT LLC
$339.0M14,992,081 shMORGAN STANLEY
$98.3M4,347,748 shDODGE & COX
$86.5M3,826,910 shFIDUCIARY MANAGEMENT INC /WI/
$66.4M2,937,829 shBRANDES INVESTMENT PARTNERS, LP
$43.3M1,916,090 shMILLENNIUM MANAGEMENT LLC
$35.5M1,571,805 shTODD ASSET MANAGEMENT LLC
$29.5M1,305,386 shGOLDMAN SACHS GROUP INC
$20.3M898,668 shBlackRock, Inc.
$19.5M860,302 shTEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
$18.5M816,200 sh
| Fund | Value | Shares |
|---|---|---|
| PZENA INVESTMENT MANAGEMENT LLC | $339.0M | 14,992,081 |
| MORGAN STANLEY | $98.3M | 4,347,748 |
| DODGE & COX | $86.5M | 3,826,910 |
| FIDUCIARY MANAGEMENT INC /WI/ | $66.4M | 2,937,829 |
| BRANDES INVESTMENT PARTNERS, LP | $43.3M | 1,916,090 |
| MILLENNIUM MANAGEMENT LLC | $35.5M | 1,571,805 |
| TODD ASSET MANAGEMENT LLC | $29.5M | 1,305,386 |
| GOLDMAN SACHS GROUP INC | $20.3M | 898,668 |
| BlackRock, Inc. | $19.5M | 860,302 |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | $18.5M | 816,200 |
Companies Similar to FMS
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
KONINKLIJKE PHILIPS NV
HENRY SCHEIN INC
GE HealthCare Technologies Inc.
SMITH & NEPHEW PLC
TAKEDA PHARMACEUTICAL CO LTD
GSK plc
HEALTHCARE SERVICES GROUP INC
Solstice Advanced Materials Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put FMS on your watchlist
Track score changes the day Fresenius Medical Care AG files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is FMS a good stock to buy?
13F Pro's AI-powered analysis of Fresenius Medical Care AG (FMS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for FMS are available on the FMS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. FMS is classified as a mid company.
Which hedge funds own FMS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling FMS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Fresenius Medical Care AG's investment landscape.